Cerebras Systems Inc.
Securities Investigation
Investors who purchased or acquired CBRS securities are encouraged to come forward.
Investigation opened October 29, 2026
Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Cerebras Systems Inc. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Cerebras Systems Inc. (CBRS) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, is investigating potential claims on behalf of shareholders of Cerebras Systems Inc (NASDAQ: CBRS).
What Potential Securities Violations Is BG&G Investigating?
- 1Whether Cerebras Systems Inc. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- 2Whether Cerebras Systems Inc. failed to disclose material adverse information that would have been significant to a reasonable investor.
- 3Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
Key Dates
An investigation is not a lawsuit. If a complaint is filed, a lead plaintiff deadline will be set and posted here.
Why Did CBRS Stock Drop?
On October 28, 2026, short seller Culper Research published a report alleging that Cerebras’s massive silicon wafers suffer from severe engineering flaws, resulting in an actual functional field lifespan of just 1.5 to 2.5 years. Culper further alleged that a proprietary connector material claimed by CEO Andrew Feldman to have been invented in-house is actually an off-the-shelf product from a third-party vendor. The report also claims that Cerebras programs its wafers to run continuous “dummy operations” to prevent them from cooling down and fracturing, forcing systems to run near peak power constantly and rapidly degrade. Culper also questioned a sudden extension in the assumed useful life of its data center equipment from 1.5–3 years to 3–5 years between early draft filings and its ultimate IPO registration statements, a modification that allegedly inflated reported first-half gross margins. Following this news, Cerebras’s stock price fell $6.75 per share, or 5.66%, to close at $112.56 per share on October 28, 2026.
How Is Cerebras Systems Inc. (NASDAQ: CBRS) Stock Trading Today?
What Happens After You Contact Us?
Tell us about your purchase
Takes about a minute. Share count and statements are optional.
We review your transactions
Our team reviews your trades at no cost or obligation.
We keep you updated
If a case is filed, we'll contact you about your options and any deadlines.
Submitting information does not create an attorney-client relationship. Our firm works on a contingency fee basis, and you do not need to have sold your shares to contact us.
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace."
Frequently Asked Questions
Has a lawsuit been filed against Cerebras Systems Inc.?
No complaint has been filed. BG&G is investigating whether investors may have claims. If a securities class action is filed, this page will be updated with the court, class period, and lead plaintiff deadline.
What does a securities investigation mean?
The firm is reviewing public disclosures, stock price movements, and other information to determine whether a company or its officers may have violated the federal securities laws. An investigation does not mean wrongdoing has been established.
Why should I contact the firm now?
Sharing your information early lets us review your transactions and notify you promptly if a case is filed, including any deadline to seek appointment as lead plaintiff.
Does it cost anything?
No. Our firm works on a contingency fee basis, and there is no cost or obligation to contact us.
I sold my CBRS shares. Can I still contact you?
Yes. Potential claims generally depend on when you purchased and whether you suffered a loss, not on whether you still hold the shares.
What documents should I have ready?
Brokerage statements or trade confirmations showing your CBRS purchases, sales, and holdings, including dates, share counts, and prices.